The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.50
Bid: 6.00
Ask: 7.00
Change: 0.00 (0.00%)
Spread: 1.00 (16.667%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.50
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WhiteRock Capital Partners update

6 Dec 2013 07:00

RNS Number : 8530U
Braveheart Investment Group plc
06 December 2013
 



06 December 2013

WhiteRock Capital Partners Update

Braveheart Investment Group plc (the 'Group' or the 'Company'), the AIM-listed investment management group providing debt and equity capital to SMEs and servicing the investment requirements of business angels, high net worth individuals, family offices, and public sector organisations is pleased to announce that the £50million Northern Ireland Growth Loan Fund ('GLF', 'Growth Loan Fund') has, to date, approved 50 loans, totalling in excess of £12million.

WhiteRock Capital Partners LLP ('WCP') was formed to manage the GLF having been established in 2012 by Braveheart Investment Group, Clarendon Fund Managers Ltd and NEL Fund Managers Ltd.

During quarter two of the current financial year, loans have included £1,000,000 to Budget Energy Limited, a low-cost energy provider, £300,000 to Copas Technologies Ltd, a precision engineering company supplying components to the aerospace industry, and a significant investment in Lowden Guitars, manufacturers of hand-crafted acoustic guitars.

WCP recently completed a series of six regional roadshows meeting with over 100 accountants, lawyers, bankers and MLAs (Members of the Northern Ireland Legislative Assembly) to provide an update on the Fund's performance to date and to brief advisers on its SME loan product. 

Further information:

Braveheart Investment Group plc

Geoffrey Thomson, Chief Executive Tel: 01738 587555

gthomson@braveheartgroup.co.uk

 

Sanlam Securities UK Limited (Nominated Adviser and Broker to Braveheart)

Lindsay Mair Tel: 020 7628 2200

Catherine Miles

 

WhiteRock Capital Partners LLP

Paul Millar Tel: 028 9500 1060

paulmillar@whiterockcp.co.uk

 

Media Enquiries:

Allerton Communications

Peter Curtain Tel: 020 3137 2500

peter.curtain@allertoncomms.co.uk

 

Notes to Editors

 

Braveheart Investment Group plc

 

Braveheart provides financing and associated advisory services for small and medium sized enterprises (SMEs) as follows:

 

For the company looking to raise money, we provide:

· Equity Capital. This form of financing is typically long term and is usually appropriate for fast growing business or early stage companies. We will consider equity financings where our individual investment, or the investment we arrange, would normally be a maximum of £2m although we are happy to participate in larger financings as part of a syndicate;

· Debt Finance. Short to medium term and for companies with cash flow to service the loan. Out unit size for this type of finance is up to £1m and we will usually provide junior debt which is unsecured but linked to an equity instrument;

· Corporate finance advice on all aspects of raising money, strategic development and corporate governance.

 

The money we invest comes from a variety of sources (see below) and is sometimes linked to particular geographical locations.

 

To the investor, we provide a one-stop shop service to those in one of the following groups who are looking for exposure to SME investments:

· High net worth (HNW) individuals looking to build tax efficient Enterprise Investment Scheme (EIS) and Seed EIS portfolios;

· Family offices and private sector institutions;

· The Public sector.

Investors can choose between investment types ranging from self-build portfolios, to a full fund management service.

 

www.braveheartgroup.co.uk

 

WhiteRock Capital Partners LLP

WhiteRock Capital Partners LLP was established in 2012 by Braveheart Investment Group and consortium partners NEL Fund Managers and Clarendon Fund Managers to manage the Northern Ireland Growth Loan Fund.

The Growth Loan Fund will provide loans, primarily unsecured in nature, of between £50,000 and £500,000 over the next 5 years to Small and Medium Enterprises (SMEs). Loans will be made to businesses that can demonstrate sales and profitability growth or growth potential. The Fund is targeting businesses with export potential which are mainly in the manufacturing, engineering or tradable services sectors.

The Fund is run on a fully commercial basis. Finance for the Fund has been provided by Invest NI (£25m), partly through the European Regional Development Fund, with additional finance provided by the private sector.

www.whiterockcp.co.uk

 

Growth Loan Fund

 

Finance for the £50m Growth Loan Fund - which provides mezzanine finance to established Northern Ireland SMEs seeking access to growth finance - has been provided by Invest Northern Ireland and private investor, Northern Ireland Local Government Officer's Superannuation Committee (NILGOSC). WhiteRock Capital Partners LLP has been established to respond to enquiries to the Fund by the consortium of three partners - Strathtay Ventures Limited; NEL Fund Managers and Clarendon Fund Managers, all of which are authorised and regulated by the FCA. Companies seeking funding from the Growth Loan Fund must be based in Northern Ireland, demonstrating growth potential and generally be in the manufacturing, engineering or tradable services sectors. Loan will be typically unsecured and personal guarantees will not be sought. The loans provided are expected to be complementary to existing sources of finance, including banks, trade finance sources and equity investors. Loans are provided on a fully commercial basis, with monthly loan repayments required over typically a five-year term.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSMFMIFDSEDE
Date   Source Headline
29th Apr 20242:07 pmRNSHolding(s) in Company
29th Apr 20241:42 pmRNSBlock admission six monthly return
10th Apr 20247:00 amRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSAcquisition of further interest in Autins Group
4th Mar 202411:48 amRNSInvestment update – Paraytec Limited
4th Mar 20247:00 amRNSCompletion of sale of Phasefocus
9th Jan 202412:00 pmRNSHolding(s) in Company
22nd Dec 20231:30 pmRNSHolding(s) in Company
22nd Dec 20237:00 amRNSPortfolio update - Proposed sale of Phasefocus
15th Dec 202311:41 amRNSInvestment update - Paraytec Limited
15th Dec 202310:16 amRNSReplacement: Half-year Report
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSInvestment update - Paraytec Limited
14th Nov 20239:02 amRNSHolding(s) in Company
17th Oct 20237:00 amRNSInvestment update – Paraytec Limited
10th Oct 202311:15 amRNSHolding(s) in Company
8th Sep 20237:00 amRNSInvestment update – Kirkstall Limited
8th Sep 20237:00 amRNSBlock admission six monthly return
21st Aug 20237:00 amRNSFurther investment in Phasefocus Holdings Limited
28th Jul 20232:25 pmRNSInvestment update on Paraytec Limited
28th Jul 202311:54 amRNSResult of AGM
5th Jul 20237:00 amRNSPosting of annual report and notice of AGM
4th Jul 20237:00 amRNSHolding(s) in Company
3rd Jul 20237:00 amRNSFinal Results for the year ended 31 March 2023
31st May 20237:00 amRNSInvestment update – Phasefocus Holdings Limited
3rd May 20237:00 amRNSUpdate on investments
24th Apr 202310:49 amRNSHolding(s) in Company
27th Mar 20237:00 amRNSGrant of options
13th Mar 20239:34 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSBlock admission six monthly return
10th Feb 20231:26 pmRNSHolding(s) in Company
30th Jan 20234:37 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSOperational update
22nd Dec 20229:14 amRNSHolding(s) in Company
19th Dec 20229:25 amRNSDirector/PDMR Shareholding
19th Dec 20229:11 amRNSAcquisition of interest in Image Scan Holdings plc
13th Dec 20224:37 pmRNSHolding(s) in Company
15th Nov 20223:09 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirector/PDMR Shareholding
28th Oct 20227:00 amRNSHalf-year Report
21st Oct 202210:33 amRNSHolding(s) in Company
20th Oct 20221:59 pmRNSAcquisition of further interest in Autins
5th Oct 20223:15 pmRNSHolding(s) in Company
5th Oct 202212:28 pmRNSAcquisition of further interest in Aukett Swanke
30th Sep 20225:00 pmRNSTotal Voting Rights
20th Sep 20227:00 amRNSPlacing and subscription to raise £750,000
9th Sep 20227:00 amRNSBlock admission six monthly return
6th Sep 20227:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.